Alopecia areata update: part II. Treatment.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 20115946)

Published in J Am Acad Dermatol on February 01, 2010

Authors

Abdullah Alkhalifah1, Adel Alsantali, Eddy Wang, Kevin J McElwee, Jerry Shapiro

Author Affiliations

1: Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.

Associated clinical trials:

Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata | NCT03800979

Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata | NCT04003376

Articles citing this

What causes alopecia areata? Exp Dermatol (2013) 1.14

Successful treatment of alopecia areata with topical calcipotriol. Ann Dermatol (2012) 0.86

Alopecia: evaluation and treatment. Clin Cosmet Investig Dermatol (2011) 0.86

Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells. AAPS J (2013) 0.86

Alopecia areata: a new treatment plan. Clin Cosmet Investig Dermatol (2011) 0.82

Efficacy and safety of methotrexate in alopecia areata. An Bras Dermatol (2014) 0.81

Intralesional steroids for alopecia areata. Int J Trichology (2010) 0.80

Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata. JCI Insight (2016) 0.78

Molecular signatures define alopecia areata subtypes and transcriptional biomarkers. EBioMedicine (2016) 0.78

Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model. Cell Stress Chaperones (2011) 0.78

Clinical characteristics and prognostic factors in early-onset alopecia totalis and alopecia universalis. J Korean Med Sci (2012) 0.78

'Ho-ver'ing Over Alopecia Areata: Histopathological Study of 50 Cases. Int J Trichology (2014) 0.75

Erythroid Differentiation Regulator 1 as a Novel Biomarker for Hair Loss Disorders. Int J Mol Sci (2017) 0.75

Alopecia Areata Increases the Risk of Stroke: a 3-year Follow-Up Study. Sci Rep (2015) 0.75

Angiotensin converting enzyme activity in alopecia areata. Enzyme Res (2014) 0.75

Treatment of alopecia universalis with oral alitretinoin: A case report. JAAD Case Rep (2017) 0.75

Current treatment strategies in pediatric alopecia areata. Indian J Dermatol (2012) 0.75

A Comparative Study of Oral Cyclosporine and Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata. Ann Dermatol (2016) 0.75

The role of lymphocytes in the development and treatment of alopecia areata. Expert Rev Clin Immunol (2015) 0.75

Hydroxychloroquine is ineffective in treatment of alopecia totalis and extensive alopecia areata: A case series of 8 patients. JAAD Case Rep (2016) 0.75

Alopecia Areata: An Update on Treatment Options for Children. Paediatr Drugs (2017) 0.75

Vitamin D Level in Alopecia Areata. Indian J Dermatol (2017) 0.75

Articles by these authors

Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol (2010) 2.48

Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2008) 1.99

Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol (2005) 1.80

Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model. J Invest Dermatol (2008) 1.62

Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation. J Am Acad Dermatol (2004) 1.53

Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss. J Invest Dermatol (2010) 1.48

Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol (2004) 1.42

Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001. J Am Acad Dermatol (2003) 1.42

Folliculitis decalvans. Dermatol Ther (2008) 1.32

Endogenous retinoids in the pathogenesis of alopecia areata. J Invest Dermatol (2012) 1.28

A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women. J Am Acad Dermatol (2007) 1.23

Frontal fibrosing alopecia: a retrospective clinical review of 62 patients with treatment outcome and long-term follow-up. Int J Dermatol (2014) 1.17

Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. J Invest Dermatol (2002) 1.17

CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomas. Am J Pathol (2010) 1.15

Update on primary cicatricial alopecias. J Am Acad Dermatol (2005) 1.13

Androgenetic alopecia. Endocrinol Metab Clin North Am (2007) 1.13

Lichen planopilaris. Dermatol Ther (2008) 1.13

Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. J Invest Dermatol (2003) 1.12

The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results. Exp Dermatol (2008) 1.12

Primary cicatricial alopecias: clinicopathology of 112 cases. J Am Acad Dermatol (2004) 1.05

Using the internet to assess and teach medical students in dermatology. J Cutan Med Surg (2002) 1.02

Management of hair loss. Dermatol Clin (2005) 1.02

Alopecia areata: treatment of today and tomorrow. J Investig Dermatol Symp Proc (2003) 1.00

Successful treatment of temporal triangular alopecia by hair restoration surgery using follicular unit transplantation. Dermatol Surg (2009) 0.99

Etiopathogenesis of alopecia areata: Why do our patients get it? Dermatol Ther (2011) 0.93

Alopecia areata. Curr Dir Autoimmun (2008) 0.92

Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles. J Invest Dermatol (2008) 0.92

Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata. J Invest Dermatol (2002) 0.90

Alopecia areata: pathogenesis and potential for therapy. Expert Rev Mol Med (2006) 0.90

Central hair loss in African American women: incidence and potential risk factors. J Am Acad Dermatol (2010) 0.90

The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia. J Am Acad Dermatol (2003) 0.89

A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma. BMC Cancer (2014) 0.88

Diagnosis and management of primary cicatricial alopecia: part I. Skinmed (2008) 0.88

Reduced expression of interleukin-2 decreases the frequency of alopecia areata onset in C3H/HeJ mice. J Invest Dermatol (2005) 0.88

Pseudopelade of Brocq. Dermatol Ther (2008) 0.88

What can we learn from animal models of Alopecia areata? Dermatology (2005) 0.87

Hypothesis testing: CTLA4 co-stimulatory pathways critical in the pathogenesis of human and mouse alopecia areata. J Invest Dermatol (2011) 0.86

Immunotherapy of melanoma: present options and future promises. Cancer Metastasis Rev (2015) 0.86

Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients. J Autoimmun (2004) 0.86

Integrin β6-deficient mice show enhanced keratinocyte proliferation and retarded hair follicle regression after depilation. J Invest Dermatol (2011) 0.85

Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study. Dermatology (2008) 0.85

Restoration of hair growth with topical diphencyprone in mouse and rat models of alopecia areata. J Am Acad Dermatol (2003) 0.85

Interleukin-10-deficient mice are less susceptible to the induction of alopecia areata. J Invest Dermatol (2002) 0.85

Dissecting cellulitis of the scalp. Dermatol Online J (2012) 0.83

Androgens and hair loss. Curr Opin Endocrinol Diabetes Obes (2009) 0.83

Examining the relationship between alopecia areata, androgenetic alopecia, and emotional intelligence. J Cutan Med Surg (2013) 0.83

Wigs and hairpieces: evaluating dermatologic issues. Dermatol Ther (2012) 0.83

The progressive state, in contrast to the stable or regressive state of alopecia areata, is reflected in peripheral blood mononuclear cells. Exp Dermatol (2004) 0.81

Interleukin-6 cytokine family member oncostatin M is a hair-follicle-expressed factor with hair growth inhibitory properties. Exp Dermatol (2007) 0.81

Pattern hair loss in men: diagnosis and medical treatment. Dermatol Clin (2012) 0.81

Paradoxical hypertrichosis after laser epilation. J Am Acad Dermatol (2005) 0.81

European Consensus on the evaluation of women presenting with excessive hair growth. Eur J Dermatol (2009) 0.80

Hair transplantation update: procedural techniques, innovations, and applications. Dermatol Clin (2012) 0.80

Somatostatin expression in human hair follicles and its potential role in immune privilege. J Invest Dermatol (2013) 0.80

Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study. Arch Dermatol (2009) 0.80

Regeneration of a new hair follicle from the upper half of a human hair follicle in a nude mouse. J Invest Dermatol (2002) 0.80

Assessment of hair density and caliber in Caucasian and Asian female subjects with female pattern hair loss by using the Folliscope. J Am Acad Dermatol (2012) 0.79

Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice. J Investig Dermatol Symp Proc (2003) 0.78

Secondary cicatricial and other permanent alopecias. Dermatol Ther (2008) 0.78

Deficiency in nucleotide excision repair family gene activity, especially ERCC3, is associated with non-pigmented hair fiber growth. PLoS One (2012) 0.78

Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata. J Am Acad Dermatol (2005) 0.78

Uncombable hair syndrome. J Am Acad Dermatol (2009) 0.77

Cytokines and signal transduction pathways mediated by anthralin in alopecia areata-affected Dundee experimental balding rats. J Investig Dermatol Symp Proc (2003) 0.76

The basic science of hair biology: what are the causal mechanisms for the disordered hair follicle? Dermatol Clin (2012) 0.76

Old wine in new bottles: reviving old therapies for alopecia areata using rodent models. J Investig Dermatol Symp Proc (2003) 0.76

Discoid lupus erythematosus presenting with cysts, comedones, and cicatricial alopecia on the scalp. J Am Acad Dermatol (2009) 0.76

Topical mechlorethamine restores autoimmune-arrested follicular activity in mice with an alopecia areata-like disease by targeting infiltrated lymphocytes. J Invest Dermatol (2003) 0.76

Diagnosis and management of primary cicatricial alopecia: part II. Skinmed (2008) 0.76

Early stage alopecia areata is associated with inflammation in the upper dermis and damage to the hair follicle infundibulum. Australas J Dermatol (2013) 0.75

Development of autoimmune hair loss disease alopecia areata is associated with cardiac dysfunction in C3H/HeJ mice. PLoS One (2013) 0.75

Occupational alopecia or alopecia areata? J Am Acad Dermatol (2002) 0.75

Lichen planopilaris and pseudopelade of Brocq involve distinct disease associated gene expression patterns by microarray. J Dermatol Sci (2009) 0.75

Break dancing: a new risk factor for scarring hair loss. J Cutan Med Surg (2011) 0.75

The Infatuation With Biotin Supplementation: Is There Truth Behind Its Rising Popularity? A Comparative Analysis of Clinical Efficacy versus Social Popularity. J Drugs Dermatol (2017) 0.75

Folliculitis decalvans developing 20 years after hair restoration surgery in punch grafts: case report. Dermatol Surg (2009) 0.75

Efficacy of a day-care program in the treatment of psoriasis. J Cutan Med Surg (2008) 0.75

Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Dermatol Ther (2014) 0.75

Topical agents for hair growth promotion: what is out there? Skin Therapy Lett (2013) 0.75

Retrospective Review of Folliculitis Decalvans in 23 Patients with Course and Treatment Analysis of Long-standing Cases. J Cutan Med Surg (2014) 0.75

Inner canthus hypertrichosis: a side effect of prostaglandin analogue treatment for glaucoma. J Cutan Med Surg (2011) 0.75

Successful hair re-growth with multimodal treatment of early cicatricial alopecia in discoid lupus erythematosus. Acta Derm Venereol (2009) 0.75

Update on male pattern hair loss. J Drugs Dermatol (2014) 0.75

Topical nitrogen mustard in the treatment of alopecia areata: a bilateral comparison study. J Am Acad Dermatol (2003) 0.75

Rapp-Hodgkin syndrome: a review of the aspects of hair and hair color. J Am Acad Dermatol (2005) 0.75

Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study. J Drugs Dermatol (2016) 0.75